BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28542222)

  • 1. Differential expression of islet glutaredoxin 1 and 5 with high reactive oxygen species production in a mouse model of diabesity.
    Petry SF; Sharifpanah F; Sauer H; Linn T
    PLoS One; 2017; 12(5):e0176267. PubMed ID: 28542222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent antioxidant capacity of human islet cell subsets: A potential cause of beta-cell vulnerability in diabetes and islet transplantation.
    Miki A; Ricordi C; Sakuma Y; Yamamoto T; Misawa R; Mita A; Molano RD; Vaziri ND; Pileggi A; Ichii H
    PLoS One; 2018; 13(5):e0196570. PubMed ID: 29723228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of toll-like receptor 4 and inflammatory cytokines, interleukin-6 in particular, in islets from a mouse model of obesity and type 2 diabetes.
    Ladefoged M; Buschard K; Hansen AM
    APMIS; 2013 Jun; 121(6):531-8. PubMed ID: 23134512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elovl6 Deficiency Improves Glycemic Control in Diabetic
    Zhao H; Matsuzaka T; Nakano Y; Motomura K; Tang N; Yokoo T; Okajima Y; Han SI; Takeuchi Y; Aita Y; Iwasaki H; Yatoh S; Suzuki H; Sekiya M; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
    Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role.
    Meghana K; Sanjeev G; Ramesh B
    Eur J Pharmacol; 2007 Dec; 577(1-3):183-91. PubMed ID: 17900558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced insulin secretion function is associated with pancreatic islet redistribution of cell adhesion molecules (CAMS) in diabetic mice after prolonged high-fat diet.
    Falcão VT; Maschio DA; de Fontes CC; Oliveira RB; Santos-Silva JC; Almeida AC; Vanzela EC; Cartaxo MT; Carvalho CP; Collares-Buzato CB
    Histochem Cell Biol; 2016 Jul; 146(1):13-31. PubMed ID: 27020567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin 3 regulates mouse pancreatic beta cell function and is suppressed in pancreatic islets isolated from human type 2 diabetic patients.
    Caton PW; Richardson SJ; Kieswich J; Bugliani M; Holland ML; Marchetti P; Morgan NG; Yaqoob MM; Holness MJ; Sugden MC
    Diabetologia; 2013 May; 56(5):1068-77. PubMed ID: 23397292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.
    Hayden MR; Tyagi SC
    JOP; 2002 Jul; 3(4):86-108. PubMed ID: 12110767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of TFB1M results in mitochondrial dysfunction that leads to impaired insulin secretion and diabetes.
    Sharoyko VV; Abels M; Sun J; Nicholas LM; Mollet IG; Stamenkovic JA; Göhring I; Malmgren S; Storm P; Fadista J; Spégel P; Metodiev MD; Larsson NG; Eliasson L; Wierup N; Mulder H
    Hum Mol Genet; 2014 Nov; 23(21):5733-49. PubMed ID: 24916378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of surface camouflaged islet transplantation on pathophysiological progression in a db/db type 2 diabetic mouse model.
    Jeong JH; Yook S; Lee H; Ahn CH; Lee DY; Byun Y
    Biochem Biophys Res Commun; 2013 Apr; 433(4):513-8. PubMed ID: 23523788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired insulin turnover in islets from type 2 diabetic patients.
    Ehehalt F; Knoch K; Erdmann K; Krautz C; Jäger M; Steffen A; Wegbrod C; Meisterfeld R; Kersting S; Bergert H; Kuhlisch E; Bornstein S; Bonifacio E; Saeger HD; Solimena M
    Islets; 2010; 2(1):30-6. PubMed ID: 21099291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lepr(db) mouse model of type 2 diabetes: pancreatic islet isolation and live-cell 2-photon imaging of intact islets.
    Do OH; Low JT; Thorn P
    J Vis Exp; 2015 May; (99):e52632. PubMed ID: 25992768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed mechanisms for oligonucleotide IMT504 induced diabetes reversion in a mouse model of immunodependent diabetes.
    Bianchi MS; Bianchi S; Hernado-Insúa A; Martinez LM; Lago N; Libertun C; Chasseing NA; Montaner AD; Lux-Lantos VA
    Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E380-95. PubMed ID: 27329801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger.
    Lupi R; Del Guerra S; Mancarella R; Novelli M; Valgimigli L; Pedulli GF; Paolini M; Soleti A; Filipponi F; Mosca F; Boggi U; Del Prato S; Masiello P; Marchetti P
    Diabetes Metab; 2007 Nov; 33(5):340-5. PubMed ID: 17616474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes.
    Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice.
    Chu KY; Leung PS
    Antioxid Redox Signal; 2007 Jul; 9(7):869-78. PubMed ID: 17508912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCF1 links GIPR signaling to the control of beta cell function and survival.
    Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
    Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutaredoxins concomitant with optimal ROS activate AMPK through S-glutathionylation to improve glucose metabolism in type 2 diabetes.
    Dong K; Wu M; Liu X; Huang Y; Zhang D; Wang Y; Yan LJ; Shi D
    Free Radic Biol Med; 2016 Dec; 101():334-347. PubMed ID: 27743883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes.
    Novelli M; Pocai A; Lajoix AD; Beffy P; Bezzi D; Marchetti P; Gross R; Masiello P
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):77-82. PubMed ID: 15149729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.